Literature DB >> 23871655

Identification of a T7 RNA polymerase variant that permits the enzymatic synthesis of fully 2'-O-methyl-modified RNA.

Jenny Ibach1, Laura Dietrich, Kyra R M Koopmans, Nico Nöbel, Marc Skoupi, Susanne Brakmann.   

Abstract

T7 RNA polymerase is an important biocatalyst that is used in diverse biotechnological applications such as in vitro transcription or protein expression. The enzyme displays high substrate specificity which is payed by significant limitations regarding incorporation of synthetic nucleotide analogs. Of specific interest is enzymatic synthesis of 2'-O-methyl-modified RNA as these nucleic acids exhibit improved biochemical and pharmacokinetic properties that make them attractive for diagnostic and therapeutic purposes. We report here on the development of an activity-based selection/screening approach for assessing polymerase activities in the presence of 2'-O-methyl-modified nucleotides, and on the identification of one variant T7 RNA polymerase which is capable of synthesizing all-2'-O-methyl RNA.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aptamer; Modified nucleotide; Polymerase; RNA

Mesh:

Substances:

Year:  2013        PMID: 23871655     DOI: 10.1016/j.jbiotec.2013.07.005

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  14 in total

Review 1.  In vitro selection using modified or unnatural nucleotides.

Authors:  Scott M Knudsen; Michael P Robertson; Andrew D Ellington
Journal:  Curr Protoc Nucleic Acid Chem       Date:  2002-02

2.  Stabilized Interleukin-6 receptor binding RNA aptamers.

Authors:  Cindy Meyer; Katharina Berg; Katja Eydeler-Haeder; Inken Lorenzen; Joachim Grötzinger; Stefan Rose-John; Ulrich Hahn
Journal:  RNA Biol       Date:  2013-12-20       Impact factor: 4.652

3.  Highly stable aptamers selected from a 2'-fully modified fGmH RNA library for targeting biomaterials.

Authors:  Adam D Friedman; Dongwook Kim; Rihe Liu
Journal:  Biomaterials       Date:  2015-01       Impact factor: 12.479

Review 4.  In vitro selection using modified or unnatural nucleotides.

Authors:  Gwendolyn M Stovall; Robert S Bedenbaugh; Shruti Singh; Adam J Meyer; Paul J Hatala; Andrew D Ellington; Bradley Hall
Journal:  Curr Protoc Nucleic Acid Chem       Date:  2014-03-26

5.  A two-residue nascent-strand steric gate controls synthesis of 2'-O-methyl- and 2'-O-(2-methoxyethyl)-RNA.

Authors:  Niklas Freund; Alexander I Taylor; Sebastian Arangundy-Franklin; Nithya Subramanian; Sew-Yeu Peak-Chew; Amy M Whitaker; Bret D Freudenthal; Mikhail Abramov; Piet Herdewijn; Philipp Holliger
Journal:  Nat Chem       Date:  2022-10-13       Impact factor: 24.274

Review 6.  The expanding world of DNA and RNA.

Authors:  Tingjian Chen; Narupat Hongdilokkul; Zhixia Liu; Deepak Thirunavukarasu; Floyd E Romesberg
Journal:  Curr Opin Chem Biol       Date:  2016-08-24       Impact factor: 8.822

7.  Transcription yield of fully 2'-modified RNA can be increased by the addition of thermostabilizing mutations to T7 RNA polymerase mutants.

Authors:  Adam J Meyer; Daniel J Garry; Bradley Hall; Michelle M Byrom; Hannah G McDonald; Xu Yang; Y Whitney Yin; Andrew D Ellington
Journal:  Nucleic Acids Res       Date:  2015-07-24       Impact factor: 16.971

Review 8.  Towards XNA nanotechnology: new materials from synthetic genetic polymers.

Authors:  Vitor B Pinheiro; Philipp Holliger
Journal:  Trends Biotechnol       Date:  2014-04-15       Impact factor: 19.536

9.  Evolution of thermophilic DNA polymerases for the recognition and amplification of C2'-modified DNA.

Authors:  Tingjian Chen; Narupat Hongdilokkul; Zhixia Liu; Ramkrishna Adhikary; Shujian S Tsuen; Floyd E Romesberg
Journal:  Nat Chem       Date:  2016-04-18       Impact factor: 24.427

10.  Post-ExSELEX stabilization of an unnatural-base DNA aptamer targeting VEGF165 toward pharmaceutical applications.

Authors:  Michiko Kimoto; Mana Nakamura; Ichiro Hirao
Journal:  Nucleic Acids Res       Date:  2016-07-07       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.